These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1607758)
1. [Immunohistological study on HLA class II antigen expression and lymphocyte infiltration in cancer tissues of the uterine cervix]. Nakamura M Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):349-56. PubMed ID: 1607758 [TBL] [Abstract][Full Text] [Related]
2. [An immunohistochemical study on regional immunological response of uterine cervical cancer]. Okamoto Y Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):456-62. PubMed ID: 2373918 [TBL] [Abstract][Full Text] [Related]
3. [A study of the expression of class II antigen on uterine cervical cancer cells and cell lines]. Okamoto Y; Ueda M; Yamada T; Misaki O; Seiki Y; Tsurunaga T; Iwai E; Ueki M; Sugimoto O Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1819-25. PubMed ID: 2974857 [TBL] [Abstract][Full Text] [Related]
4. Tissue evaluation of immune markers in endometrial and cervical carcinomas. Lazaris ACh; Chatzigianni EB; Xidias G; Panoskaltsis TA; Thomopoulou GC; Eftychiadis CA; Michalas S; Patsouris ES J Exp Clin Cancer Res; 2004 Jun; 23(2):269-75. PubMed ID: 15354412 [TBL] [Abstract][Full Text] [Related]
5. [An immunohistochemical study with monoclonal antibodies on lymphocytes infiltrating in cervical cancer]. Okamoto Y; Sano T; Okamura S; Ueki M; Sugimoto O Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jun; 39(6):925-32. PubMed ID: 3302069 [TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study on the MHC class I antigen expression on squamous cell carcinoma of the uterine cervix]. Honma S; Nakamura M; Maruhashi T; Kodama S; Obata N; Kanazawa K; Takahashi T; Sasagawa S; Takeuchi S Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):813-8. PubMed ID: 2677169 [TBL] [Abstract][Full Text] [Related]
7. HLA class II antigen expression in human papillomavirus-associated cervical cancer. Glew SS; Duggan-Keen M; Cabrera T; Stern PL Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602 [TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133 [TBL] [Abstract][Full Text] [Related]
9. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance. Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840 [TBL] [Abstract][Full Text] [Related]
10. [Immunohistological studies on the identification of T cells and T cell subsets infiltrating in human stomach cancer tissues]. Kasai K; Imamura M; Hiratsuka H; Usui T; Kamiya H; Muroya K; Narimatsu H; Minase A; Totsuka M; Kikuchi K Gan No Rinsho; 1983 Aug; 29(9):981-6. PubMed ID: 6352990 [TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic analysis of the transformation zone of human cervix. Roncalli M; Sideri M; Giè P; Servida E Lab Invest; 1988 Feb; 58(2):141-9. PubMed ID: 2448545 [TBL] [Abstract][Full Text] [Related]
12. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis. Aichinger G; Fill H; Wick G Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622 [TBL] [Abstract][Full Text] [Related]
13. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma. Ryschich E; Nötzel T; Hinz U; Autschbach F; Ferguson J; Simon I; Weitz J; Fröhlich B; Klar E; Büchler MW; Schmidt J Clin Cancer Res; 2005 Jan; 11(2 Pt 1):498-504. PubMed ID: 15701833 [TBL] [Abstract][Full Text] [Related]
14. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2. Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611 [TBL] [Abstract][Full Text] [Related]
15. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line. Yamamoto M; Yano A J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233 [TBL] [Abstract][Full Text] [Related]
16. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies. Nowak JS; Lanzrein C Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835 [TBL] [Abstract][Full Text] [Related]
17. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Jansson R; Karlsson A; Forsum U Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731 [TBL] [Abstract][Full Text] [Related]
18. Identification of normal and transformed lymphocyte subsets of nonhuman primates with monoclonal antibodies to human lymphocytes. Neubauer RH; Briggs CJ; Noer KB; Rabin H J Immunol; 1983 Mar; 130(3):1323-9. PubMed ID: 6296233 [TBL] [Abstract][Full Text] [Related]
19. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Scheynius A; Klareskog L; Forsum U Clin Exp Immunol; 1982 Aug; 49(2):325-30. PubMed ID: 6751638 [TBL] [Abstract][Full Text] [Related]
20. [Research into the human leucocyte antigen I deletion and local lymphocytes infiltration in laryngeal carcinoma]. Niu C; Liu X; Zhou W; Jing L; Du B Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Jun; 37(3):215-8. PubMed ID: 12772327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]